Presentation is loading. Please wait.

Presentation is loading. Please wait.

Supplementary figure 1.

Similar presentations


Presentation on theme: "Supplementary figure 1."— Presentation transcript:

1 Supplementary figure 1

2 Supplementary figure 2 Deletion No CNA Amplification MCL1
BCL2 BCL2A1 BCL2L1 (bcl-xl) BCL2L2 (bcl-w) MCL1 (57%) BOK BIK BAK1 BAX BAD BMF HRK BIM (BCL2L11) Anti-apoptotic BCL2 family members Pro-apoptotic BCL2 family members MCL1

3 Supplementary figure 3 A B C

4 Supplementary figure 4

5 Supplementary figure 5

6 Supplementary figure 6 A B

7 Supplementary figure 7 Untreated (4 weeks) S44563 (4 weeks)
Bleomycin (4 weeks) Bleomycin + S44563 (4 weeks) Untreated (15 weeks) S44563 (15 weeks) IR (15 weeks) IR + S44563 (15 weeks)

8 Supplementary figure 8 Time (days) Tumor volume IR IR*2 Excised tumor


Download ppt "Supplementary figure 1."

Similar presentations


Ads by Google